{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:33:58Z","timestamp":1793835238897,"version":"4.6.1"},"reference-count":134,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009253","name":"EASL International Liver Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009253","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","gastrojournal.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1053\/j.gastro.2023.11.306","type":"journal-article","created":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T23:24:07Z","timestamp":1705793047000},"page":"588-604.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Hepatorenal Syndrome in Cirrhosis"],"prefix":"10.1053","volume":"166","author":[{"given":"Elisa","family":"Pose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Piano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e0","family":"Juanola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4657-4504","authenticated-orcid":false,"given":"Pere","family":"Gin\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2023.11.306_bib1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41572-018-0022-7","article-title":"Hepatorenal syndrome","volume":"4","author":"Gin\u00e8s","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1053\/j.gastro.2023.11.306_bib2","doi-asserted-by":"crossref","first-page":"m2687","DOI":"10.1136\/bmj.m2687","article-title":"Hepatorenal syndrome: pathophysiology, diagnosis, and management","volume":"370","author":"Simonetto","year":"2020","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2023.11.306_bib3","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jhep.2014.12.029","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites","volume":"62","author":"Angeli","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib4","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jhep.2019.07.002","article-title":"News in pathophysiology, definition and classification of hepatorenal syndrome: a step beyond the International Club of Ascites (ICA) consensus document","volume":"71","author":"Angeli","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib5","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jhep.2020.08.037","article-title":"Natural history of acute kidney disease in patients with cirrhosis","volume":"74","author":"Tonon","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib6","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib7","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jhep.2020.04.043","article-title":"Changing epidemiology and outcomes of acute kidney injury in hospitalized patients with cirrhosis - a US population-based study","volume":"73","author":"Desai","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib8","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/hep.22605","article-title":"Acute kidney injury in cirrhosis","volume":"48","author":"Garcia-Tsao","year":"2008","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.11.306_bib9","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1053\/j.gastro.2010.07.043","article-title":"Prognostic importance of the cause of renal failure in patients with cirrhosis","volume":"140","author":"Mart\u00edn-Llah\u00ed","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2023.11.306_bib10","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1111\/liv.13738","article-title":"Un-precipitated acute kidney injury is uncommon among stable patients with cirrhosis and ascites","volume":"38","author":"Wong","year":"2018","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2023.11.306_bib11","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jhep.2013.04.036","article-title":"A\u00a0modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis","volume":"59","author":"Fagundes","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib12","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jhep.2013.03.039","article-title":"Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites","volume":"59","author":"Piano","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib13","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.cgh.2016.09.156","article-title":"Validation of a staging system for acute kidney injury in patients with cirrhosis and association with acute-on-chronic liver failure","volume":"15","author":"Huelin","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib14","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.14309\/ajg.0000000000000670","article-title":"Hospital-acquired versus community-acquired acute kidney injury in patients with cirrhosis: a prospective study","volume":"115","author":"Patidar","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2023.11.306_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/108139","article-title":"Prognosis of acute kidney injury and hepatorenal syndrome in patients with cirrhosis: a prospective cohort study","volume":"2015","author":"Allegretti","year":"2015","journal-title":"Int J Nephrol"},{"key":"10.1053\/j.gastro.2023.11.306_bib16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/hep.1840170215","article-title":"Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime","volume":"17","author":"Toledo","year":"1993","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.11.306_bib17","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jhep.2014.01.024","article-title":"Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013","volume":"60","author":"Jalan","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib18","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1053\/jhep.2003.50447","article-title":"Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis","volume":"38","author":"Ruiz-del-Arbol","year":"2003","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.11.306_bib19","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/hep.510270507","article-title":"Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality","volume":"27","author":"Navasa","year":"1998","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.11.306_bib20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","author":"Sort","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2023.11.306_bib21","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jhep.2004.05.009","article-title":"Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"41","author":"Fern\u00e1ndez","year":"2004","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib22","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cgh.2011.11.012","article-title":"Role of albumin treatment in patients with spontaneous bacterial peritonitis","volume":"10","author":"Poca","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cgh.2012.11.007","article-title":"Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis: a meta-analysis of randomized trials","volume":"11","author":"Salerno","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib24","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa2022166","article-title":"A\u00a0randomized trial of albumin infusions in hospitalized patients with cirrhosis","volume":"384","author":"China","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2023.11.306_bib25","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/hep.25735","article-title":"Association\u00a0of AKI with mortality and complications in hospitalized patients with cirrhosis","volume":"57","author":"Belcher","year":"2013","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.11.306_bib26","first-page":"244","article-title":"Prognostic significance of acute kidney injury stage 1B in hospitalized patients with cirrhosis: a US nationwide study","volume":"30","author":"Patidar","year":"2024","journal-title":"Liver Transpl"},{"key":"10.1053\/j.gastro.2023.11.306_bib27","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.11.306_bib28","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMra0809139","article-title":"Renal failure in cirrhosis","volume":"361","author":"Gin\u00e8s","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2023.11.306_bib29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1055\/s-2007-1007294","article-title":"Peripheral arterial vasodilatation: determinant of functional spectrum of cirrhosis","volume":"14","author":"Schrier","year":"1994","journal-title":"Semin Liver Dis"},{"key":"10.1053\/j.gastro.2023.11.306_bib30","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nrgastro.2012.96","article-title":"Recent advances in our understanding of hepatorenal syndrome","volume":"9","author":"Wong","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib31","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM199808203390807","article-title":"Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis","volume":"339","author":"Martin","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2023.11.306_bib32","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1002\/hep.20993","article-title":"The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule","volume":"43","author":"Iwakiri","year":"2006","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.11.306_bib33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1053\/gast.2002.30305","article-title":"Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat","volume":"122","author":"Ros","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2023.11.306_bib34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/s-2007-1007295","article-title":"Hepatorenal disorders: role of the renin-angiotensin-aldosterone system","volume":"14","author":"Bernardi","year":"1994","journal-title":"Semin Liver Dis"},{"key":"10.1053\/j.gastro.2023.11.306_bib35","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0168-8278(98)80022-6","article-title":"The sympathetic nervous system in liver disease","volume":"29","author":"Henriksen","year":"1998","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-8278(00)80158-0","article-title":"Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome","volume":"33","author":"Uriz","year":"2000","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib37","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(03)14903-3","article-title":"Hepatorenal syndrome","volume":"362","author":"Gin\u00e8s","year":"2003","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2023.11.306_bib38","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s12072-008-9109-7","article-title":"Cirrhotic cardiomyopathy","volume":"3","author":"Wong","year":"2009","journal-title":"Hepatol Int"},{"key":"10.1053\/j.gastro.2023.11.306_bib39","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/liv.13589","article-title":"The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis","volume":"38","author":"M\u00f8ller","year":"2018","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2023.11.306_bib40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jhep.2012.08.027","article-title":"LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction","volume":"58","author":"Nazar","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib41","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep.20766","article-title":"Circulatory function and hepatorenal syndromein cirrhosis","volume":"42","author":"Ruiz-del-Arbol","year":"2005","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.11.306_bib42","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/gut.2009.180570","article-title":"Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites","volume":"59","author":"Krag","year":"2010","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2023.11.306_bib43","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.jhep.2020.05.011","article-title":"Non-selective beta-blockers impair global circulatory homeostasis and renal function in cirrhotic patients with refractory ascites","volume":"73","author":"T\u00e9llez","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib44","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/0002-9343(67)90247-1","article-title":"Renal failure in patients with cirrhosis of the liver. 3. Evaluation of intrarenal blood flow by para-aminohippurate extraction and response to angiotensin","volume":"43","author":"Schroeder","year":"1967","journal-title":"Am J Med"},{"key":"10.1053\/j.gastro.2023.11.306_bib45","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0168-8278(86)80084-8","article-title":"Redistribution of renal blood flow in patients with liver cirrhosis. The role of renal PGE2","volume":"2","author":"Sacerdoti","year":"1986","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib46","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.gastro.2007.10.055","article-title":"Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis","volume":"134","author":"Stadlbauer","year":"2008","journal-title":"Gastroenterology"},{"issue":"2B","key":"10.1053\/j.gastro.2023.11.306_bib47","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0002-9343(86)90912-5","article-title":"Renal function abnormalities, prostaglandins, and effects of nonsteroidal anti-inflammatory drugs in cirrhosis with ascites. An overview with emphasis on pathogenesis","volume":"81","author":"Arroyo","year":"1986","journal-title":"Am J Med"},{"key":"10.1053\/j.gastro.2023.11.306_bib48","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jhep.2015.04.004","article-title":"Severe acute kidney injury associated with non-steroidal anti-inflammatory drugs in cirrhosis: a case-control study","volume":"63","author":"Elia","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib49","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance","volume":"61","author":"Albillos","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib50","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jhep.2015.07.004","article-title":"Mechanisms of decompensation and organ failure in cirrhosis: from peripheral arterial vasodilation to systemic inflammation hypothesis","volume":"63","author":"Bernardi","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib51","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/liv.14037","article-title":"Characterization of inflammatory response in hepatorenal syndrome: relationship with kidney outcome and survival","volume":"39","author":"Sol\u00e9","year":"2019","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2023.11.306_bib52","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41575-021-00520-7","article-title":"Cirrhosis-associated immune dysfunction","volume":"19","author":"Albillos","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib53","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib54","series-title":"Hepatorenal Syndrome","first-page":"495","article-title":"Presentation of diagnostic criteria of the hepatorenal syndrome","author":"Earley","year":"1979"},{"key":"10.1053\/j.gastro.2023.11.306_bib55","first-page":"164","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.11.306_bib56","first-page":"1310","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"56","author":"Salerno","year":"2007","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2023.11.306_bib57","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/hep.31884","article-title":"Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"74","author":"Biggins","year":"2021","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.11.306_bib58","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1053\/j.ajkd.2020.03.016","article-title":"Clinical application of kidney biomarkers in cirrhosis","volume":"76","author":"Allegretti","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.gastro.2023.11.306_bib59","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1055\/a-1954-4136","article-title":"Novel biomarkers of AKI in cirrhosis","volume":"42","author":"Juanola","year":"2022","journal-title":"Semin Liver Dis"},{"key":"10.1053\/j.gastro.2023.11.306_bib60","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jhep.2012.03.015","article-title":"Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis","volume":"57","author":"Fagundes","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib61","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.26980","article-title":"Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury","volume":"60","author":"Belcher","year":"2014","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.11.306_bib62","doi-asserted-by":"crossref","first-page":"624","DOI":"10.5604\/01.3001.0012.0931","article-title":"Urinary neutrophil gelatinase-associated lipocalin in cirrhotic patients with acute kidney injury","volume":"17","author":"Hamdy","year":"2018","journal-title":"Ann Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib63","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/hep.30592","article-title":"Neutrophil gelatinase-associated lipocalin for assessment of acute kidney injury in cirrhosis: a prospective study","volume":"70","author":"Huelin","year":"2019","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.11.306_bib64","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000359","article-title":"Urinary NGAL as a diagnostic and prognostic marker for acute kidney injury in cirrhosis: a prospective study","volume":"12","author":"Allegretti","year":"2021","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1053\/j.gastro.2023.11.306_bib65","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1034\/j.1600-0676.2000.020001051.x","article-title":"Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients","volume":"20","author":"M\u00f8ller","year":"2000","journal-title":"Liver"},{"key":"10.1053\/j.gastro.2023.11.306_bib66","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/hep.20829","article-title":"A\u00a0randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis","volume":"42","author":"Fern\u00e1ndez","year":"2005","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.11.306_bib67","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/hep.26021","article-title":"Positive cardiac inotropic effect of albumin infusion in rodents with cirrhosis and ascites: molecular mechanisms","volume":"57","author":"Bortoluzzi","year":"2013","journal-title":"Hepatology"},{"issue":"Pt 1","key":"10.1053\/j.gastro.2023.11.306_bib68","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/jhep.2002.35819","article-title":"Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study","volume":"36","author":"Ortega","year":"2002","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.11.306_bib69","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","article-title":"A\u00a0randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2023.11.306_bib70","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","article-title":"Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study","volume":"134","author":"Mart\u00edn-Llah\u00ed","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2023.11.306_bib71","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1053\/j.gastro.2016.02.026","article-title":"Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome type 1","volume":"150","author":"Boyer","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2023.11.306_bib72","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa2008290","article-title":"Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome","volume":"384","author":"Wong","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2023.11.306_bib73","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.cgh.2018.01.035","article-title":"Association between grade of acute on chronic liver failure and response to terlipressin and albumin in patients with hepatorenal syndrome","volume":"16","author":"Piano","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib74","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jhep.2013.12.032","article-title":"Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis","volume":"60","author":"Rodr\u00edguez","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib75","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1038\/s41598-022-09505-1","article-title":"Safety and efficacy of terlipressin in acute-on-chronic liver failure with hepatorenal syndrome-acute kidney injury (HRS-AKI): a prospective cohort study","volume":"12","author":"Kulkarni","year":"2022","journal-title":"Sci Rep"},{"key":"10.1053\/j.gastro.2023.11.306_bib76","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0168-8278(97)80428-X","article-title":"Time profile of the haemodynamic effects of terlipressin in portal hypertension","volume":"26","author":"Escorsell","year":"1997","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib77","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/jgh.12195","article-title":"Hemodynamic effects of continuous versus bolus infusion of terlipressin for portal hypertension: a randomized comparison","volume":"28","author":"Ding","year":"2013","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib78","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.28396","article-title":"Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: a randomized controlled study","volume":"63","author":"Cavallin","year":"2016","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.11.306_bib80","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/apt.17195","article-title":"Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute-on-chronic liver failure","volume":"56","author":"Wong","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2023.11.306_bib82","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/j.1572-0241.2008.01828.x","article-title":"An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1hepatorenal syndrome and predictors of response","volume":"103","author":"Sharma","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2023.11.306_bib83","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2007.04.010","article-title":"Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study","volume":"47","author":"Alessandria","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib84","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jhep.2012.01.012","article-title":"Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study","volume":"56","author":"Singh","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib85","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/hep.30208","article-title":"Terlipressin is superior to noradrenaline in the management of acute kidney injury in acute on chronic liver failure","volume":"71","author":"Arora","year":"2020","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.11.306_bib86","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.510290629","article-title":"Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide","volume":"29","author":"Angeli","year":"1999","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.11.306_bib87","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s10620-006-9312-0","article-title":"Octreotide\/midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome","volume":"52","author":"Esrailian","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2023.11.306_bib88","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/hep.20262","article-title":"Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome","volume":"40","author":"Wong","year":"2004","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.11.306_bib89","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.27709","article-title":"Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: a randomized trial","volume":"62","author":"Cavallin","year":"2015","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.11.306_bib90","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hep.23283","article-title":"Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome","volume":"51","author":"Nazar","year":"2010","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.11.306_bib91","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2010.11.020","article-title":"Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics","volume":"55","author":"Boyer","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib92","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/hep.32799","article-title":"Diagnostic and prognostic performance of urinary neutrophil gelatinase-associated lipocalin in patients with cirrhosis and acute kidney injury","volume":"77","author":"Gambino","year":"2023","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.11.306_bib93","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/liv.13389","article-title":"Renal replacement therapy in critically ill liver cirrhotic patients-outcome and clinical implications","volume":"37","author":"Staufer","year":"2017","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2023.11.306_bib94","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2215\/CJN.03610417","article-title":"Prognosis of patients with cirrhosis and AKI who initiate RRT","volume":"13","author":"Allegretti","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.gastro.2023.11.306_bib95","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1523-1755.2005.00408.x","article-title":"Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy","volume":"68","author":"Wong","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.gastro.2023.11.306_bib96","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/lt.22395","article-title":"Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1","volume":"17","author":"Boyer","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1053\/j.gastro.2023.11.306_bib97","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1053\/j.gastro.2015.01.032","article-title":"Decreasing mortality among patients hospitalized with cirrhosis in the United States from 2002 through 2010","volume":"148","author":"Schmidt","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2023.11.306_bib98","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.20687","article-title":"MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation","volume":"41","author":"Alessandria","year":"2005","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.11.306_bib99","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jhep.2012.06.024","article-title":"Hepatorenal syndrome, MELD score and liver transplantation: an evolving issue with relevant implications for clinical practice","volume":"57","author":"Angeli","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib100","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jhep.2003.09.019","article-title":"Effects of treatment of hepatorenal syndrome before transplantion on posttransplantation outcomes: a case-control study","volume":"40","author":"Restuccia","year":"2004","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib101","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/ndt\/gfi212","article-title":"The course of type 1 hepato-renal syndrome postliver transplantation","volume":"21","author":"Marik","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.gastro.2023.11.306_bib102","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1002\/hep.31529","article-title":"Response to terlipressin and albumin is associated with improved liver transplant outcomes in patients with hepatorenal syndrome","volume":"73","author":"Piano","year":"2021","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.11.306_bib103","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2215\/CJN.09600912","article-title":"Short-term pretransplant renal replacement therapy and renal nonrecovery after liver transplantation alone","volume":"8","author":"Sharma","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.gastro.2023.11.306_bib104","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/lt.24049","article-title":"Outcomes of patients with cirrhosis and hepatorenal syndrome type 1 treated with liver transplantation","volume":"21","author":"Wong","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1053\/j.gastro.2023.11.306_bib105","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/MNH.0000000000000260","article-title":"Simultaneous liver kidney transplantation","volume":"25","author":"Formica","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1053\/j.gastro.2023.11.306_bib106","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1097\/TP.0000000000000963","article-title":"Canadian Forum on Combined Organ Transplantation","volume":"100","author":"Cantarovich","year":"2016","journal-title":"Transplantation"},{"key":"10.1053\/j.gastro.2023.11.306_bib107","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/ajt.13631","article-title":"Simultaneous liver-kidney allocation policy: a proposal to optimize appropriate utilization of scarce resources","volume":"16","author":"Formica","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1053\/j.gastro.2023.11.306_bib108","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/hep.510280219","article-title":"Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems","volume":"28","author":"Guevara","year":"1998","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.11.306_bib109","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.47.2.288","article-title":"Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study","volume":"47","author":"Brensing","year":"2000","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2023.11.306_bib110","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/lt.500060326","article-title":"Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial","volume":"6","author":"Mitzner","year":"2000","journal-title":"Liver Transpl"},{"key":"10.1053\/j.gastro.2023.11.306_bib111","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/gut.2008.174615","article-title":"Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment","volume":"59","author":"Wong","year":"2010","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2023.11.306_bib112","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/hep.26185","article-title":"Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial","volume":"57","author":"Ba\u00f1ares","year":"2013","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.11.306_bib113","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1053\/j.gastro.2011.12.056","article-title":"Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure","volume":"142","author":"Kribben","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2023.11.306_bib114","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s10620-021-06864-z","article-title":"Renal replacement therapy for acute kidney injury in severe alcohol-associated hepatitis as a bridge to transplant or recovery","volume":"67","author":"Jones","year":"2022","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2023.11.306_bib115","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cgh.2011.09.011","article-title":"Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis","volume":"10","author":"Altamirano","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib116","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1016\/j.cgh.2023.02.015","article-title":"Terlipressin treatment is associated with reversal of hepatorenal syndrome in patients with alcoholic hepatitis","volume":"21","author":"Sigal","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib117","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/sdi.12224","article-title":"Is there a role for dialysis in patients with hepatorenal syndrome who are not liver transplant candidates?","volume":"27","author":"Belcher","year":"2014","journal-title":"Semin Dial"},{"key":"10.1053\/j.gastro.2023.11.306_bib118","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/MOT.0000000000000507","article-title":"Early liver transplantation for severe alcoholic hepatitis: moving from controversy to consensus","volume":"23","author":"Lee","year":"2018","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1053\/j.gastro.2023.11.306_bib119","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1002\/hep4.2056","article-title":"High frequency of acute decompensation and cancer in patients with compensated cirrhosis due to nonalcoholic fatty liver disease: a retrospective cohort study","volume":"6","author":"Bassegoda","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1053\/j.gastro.2023.11.306_bib120","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S2213-8587(18)30154-2","article-title":"Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies","volume":"7","author":"Stefan","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1053\/j.gastro.2023.11.306_bib121","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jhep.2020.01.013","article-title":"NAFLD as a driver of chronic kidney disease","volume":"72","author":"Byrne","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib122","doi-asserted-by":"crossref","first-page":"E606","DOI":"10.1111\/j.1399-0012.2011.01497.x","article-title":"Implications of worse renal dysfunction and medical comorbidities in patients with NASH undergoing liver transplant evaluation: impact on MELD and more","volume":"25","author":"Park","year":"2011","journal-title":"Clin Transplant"},{"key":"10.1053\/j.gastro.2023.11.306_bib123","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/TP.0000000000000945","article-title":"Nonalcoholic steatohepatitis is the most rapidly growing indication for simultaneous liver kidney transplantation in the United States","volume":"100","author":"Singal","year":"2016","journal-title":"Transplantation"},{"key":"10.1053\/j.gastro.2023.11.306_bib124","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/liv.12381","article-title":"The impact of gender and NASH on chronic kidney disease before and after liver transplantation","volume":"34","author":"Fussner","year":"2014","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2023.11.306_bib125","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.jhep.2023.07.010","article-title":"Incidence and outcomes of acute kidney injury including hepatorenal syndrome in hospitalized patients with cirrhosis in the US","volume":"79","author":"Patidar","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib126","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/gutjnl-2016-312670","article-title":"Acute-on-chronic liver failure: an update","volume":"66","author":"Hernaez","year":"2017","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2023.11.306_bib127","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2023.11.306_bib128","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/hep.28740","article-title":"Systemic inflammation in decompensated cirrhosis: characterization and role in acute-on-chronic liver failure","volume":"64","author":"Cl\u00e0ria","year":"2016","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.11.306_bib129","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.jhep.2012.07.020","article-title":"Factors related to quality of life in patients with cirrhosis and ascites: relevance of serum sodium concentration and leg edema","volume":"57","author":"Sol\u00e0","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.11.306_bib130","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1080\/00365521.2020.1786851","article-title":"A\u00a0study on clinical outcomes of combination of terlipressin and albumin in hepatorenal syndrome","volume":"55","author":"Krishna","year":"2020","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2023.11.306_bib131","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/hep.32378","article-title":"AASLD Practice Guidance: palliative care and symptom-based management in decompensated cirrhosis","volume":"76","author":"Rogal","year":"2022","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.11.306_bib132","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/liv.13600","article-title":"Cystatin C predicts acute kidney injury and mortality in cirrhotics: a prospective cohort study","volume":"38","author":"Maiwall","year":"2018","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2023.11.306_bib133","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/hep.29290","article-title":"Plasma cystatin C is a predictor of renal dysfunction, acute-on-chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis","volume":"66","author":"Markwardt","year":"2017","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.11.306_bib134","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1002\/hep.31907","article-title":"Admission urinary and serum metabolites predict renal outcomes in hospitalized patients with cirrhosis","volume":"74","author":"Bajaj","year":"2021","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.11.306_bib136","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/S0140-6736(18)30840-7","article-title":"Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial","volume":"391","author":"Caraceni","year":"2018","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2023.11.306_bib137","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jhep.2018.08.006","article-title":"Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial","volume":"69","author":"Sol\u00e0","year":"2018","journal-title":"J\u00a0Hepatol"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508524000544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508524000544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T16:30:55Z","timestamp":1737995455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508524000544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":134,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0016508524000544"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2023.11.306","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatorenal Syndrome in Cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2023.11.306","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the AGA Institute.","name":"copyright","label":"Copyright"}]}}